Top

Journal of Hepato-Biliary-Pancreatic Sciences

Published in:

01-07-2010 | Topics

Single HCC between 2 and 5 cm: the grey zone

Surgeon’s perspective

Authors: Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, Masatoshi Makuuchi

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 4/2010

Abstract

In the treatment of hepatocellular carcinoma (HCC), control of the tumor itself, vascular invasion, and minute intrahepatic metastases is the main important factor to be considered. Based on previously reported indirect evidence, liver resection would seem to have advantages over percutaneous ablation for single HCCs measuring between 2 and 5 cm in diameter. In conclusion, liver function permitting, resection would be the therapeutic option of first choice. In cases with poor liver functional reserve, liver transplantation would be a good therapeutic option, depending on the age of the patient.

Group Formed to Establish “Guidelines for Evidence-based Clinical Practice for the Treatment of Liver Cancer”. Clinical practice guidelines for hepatocellular carcinoma. Tokyo: Kanehara & Co. Ltd; 2005 (in Japanese).

Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol. 2006;12:828–9.PubMed

Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.CrossRefPubMed

Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235–40.CrossRefPubMed

Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122–30.CrossRefPubMed

Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology. 2000;32:1224–9.CrossRefPubMed

Hasegawa K, Makuuchi M, Takayama T, for the Liver Cancer Study Group of Japan, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589–94.CrossRefPubMed

Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 2005;242:36–42.CrossRefPubMed

Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for hepatocellular carcinoma. Ann Surg. 2006;243:321–8.CrossRefPubMed

10.

Hasegawa K, Kokudo N, Makuuchi M. Surgery or ablation for hepatocellular carcinoma? Ann Surg. 2008;247:557–8.CrossRefPubMed

11.

Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2007;15:782–90.CrossRefPubMed

12.

Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1986;161:346–50.

13.

Regimbeau JM, Kianmanesh R, Farges O, et al. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002;131:311–7.CrossRefPubMed

14.

Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252–9.CrossRefPubMed

15.

Eguchi S, Kanematsu T, Arii S, Liver Cancer Study Group of Japan, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008;143:469–75.CrossRefPubMed

16.

Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–9.CrossRefPubMed

17.

Livraghi T, Lazzaroni S, Meloni F, et al. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005;92:856–8.CrossRefPubMed

18.

Imamura J, Tateishi R, Shiina S, et al. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol. 2008;103:3057–62.CrossRefPubMed

19.

Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.CrossRefPubMed

20.

Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med. 1996;334:693–9.CrossRefPubMed

Title: Single HCC between 2 and 5 cm: the grey zone
Surgeon’s perspective
Authors: Kiyoshi Hasegawa
Norihiro Kokudo
Keiji Sano
Masatoshi Makuuchi
Publication date: 01-07-2010
Publisher: Springer Japan
Published in: Journal of Hepato-Biliary-Pancreatic Sciences / Issue 4/2010
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI: https://doi.org/10.1007/s00534-009-0245-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Single HCC between 2 and 5 cm: the grey zone

Surgeon’s perspective

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Single HCC smaller than 2 cm: surgery or ablation

Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments

Surgical technique: new advancements for expanding indications and safety

Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience

Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments

Medical treatments: in association or alone, their role and their future perspectives